Joe C. Pillman

Joe Pillman is a retired partner who built a substantial practice working with local, national and international companies on a variety of corporate matters. His practice concentrated on venture capital, corporate finance, mergers and acquisitions and international law. With his extensive experience and knowledge of a wide range of transactions, Mr. Pillman successfully represented a variety of clients, and had a particular reputation for representing those in the life sciences and technology sectors.

Mr. Pillman focused on securities law, including public and private securities offerings, mergers and acquisitions, as well as a range of international matters, including public and private placements for overseas issuers, and inward and outward bound acquisition transactions. He also has extensive experience with management and leveraged buy-outs, venture capital transactions and other private fund raising issues.

Mr. Pillman's clients included companies engaged in a wide range of technology sectors such as life sciences, telecommunications equipment, networking systems, Internet infrastructure, semiconductor design and manufacture, and advanced software systems and applications products.

Honors & Awards

Mr. Pillman has regularly been named as a leading corporate practitioner in Chambers Guide to the Legal Profession. He was also recommended in the 2008, 2009, 201020112012, 2013 and 2014 editions of The Legal 500 UK for venture capital and mergers and acquisitions: mid market, with sources stating that he is "superb," "very responsive" and "well regarded for [his] advice."

Publications & News


September 18, 2015

Wilmer Cutler Pickering Hale and Dorr LLP Named a Top-Tier Firm by The Legal 500 UK

In the 2015 edition of The Legal 500 UK, WilmerHale is named a top-tier firm for dispute resolution - international arbitration and crime, fraud and licensing - fraud: white-collar crime, and is recommended in six other practice areas.

June 29, 2015

WilmerHale Reps Thermo Fisher Scientific in Agreement to Acquire Alfa Aesar

On June 25, Thermo Fisher Scientific Inc., the world leader in serving science, announced that it has signed a definitive agreement to acquire Alfa Aesar, a leading global manufacturer of research chemicals.

April 21, 2015

WilmerHale Partners Showcase Thought Leadership During Fordham IP Conference

On April 8 and 9, WilmerHale intellectual property and IP litigation partners joined an international lineup of prominent judges, government officials, academics and private practitioners for the 23rd Annual Fordham Intellectual Property Conference, held for only the second time at Cambridge University in the United Kingdom.

March 27, 2015

2015 Venture Capital Report

The 2015 Venture Capital Report offers an in-depth analysis of, and outlook for, the US and European venture capital markets. The report features industry and regional breakdowns; an analysis of trends in venture capital financing, convertible debt and VC-backed company M&A deal terms; and a look at important considerations for startup founders weighing the costs, benefits and optimal timing for company incorporation.

October 3, 2014

The Legal 500 UK Honors WilmerHale with Top Rankings in 2014 Edition

The Legal 500, the United Kingdom's guide to outstanding lawyers, has again selected WilmerHale as a top-tier law firm in dispute resolution - international arbitration, and highly recommends the firm in nine other categories. The guide also names three lawyers to its "leading individuals" list, and recognizes a total of eight of the firm’s London-based lawyers

February 3, 2014

NaturalMotion Acquired by Zynga for $527 Million

On January 30, 2014, Zynga, the world's leading provider of social game services, announced its purchase of UK game-maker NaturalMotion for $527 million in cash and equity.

September 30, 2013

WilmerHale Receives “Top Tier” Ranking in 2013 Legal 500 UK

The Legal 500, the United Kingdom's guide to outstanding lawyers, has announced its annual rankings selecting WilmerHale as a top tier law firm in dispute resolution - international arbitration, and highly recommending the firm in nine other categories.

March 28, 2013

Oxford Innovation Society (OIS) Member Profile: WilmerHale

An article by Joe Pillman, published in the Spring 2013 edition of Isis Insights, Issue 71, p. 6-7.

February 13, 2013

WilmerHale Client Oxford BioTherapeutics Nominated for 2013 Breakthrough Alliance Award™

September 24, 2012

Legal 500 UK 2012 Recognizes WilmerHale’s London Offices

Speaking Engagements

May 23-24, 2011

BioEquity Europe 2011

Paris, France

May 19-20, 2010

BioEquity Europe 2010

Zurich, Switzerland

December 12, 2006

Genesis VI Biotechnology Conference

London, UK

April 7, 2005

WilmerHale Event: AIM, LSE or NASDAQ? Which Market for Your IPO?

Oxford, UK

Recent Highlights

  • MBO of PowderMed from Chiron
  • Sale of Domantis to GSK
  • Sale of Avidex to MediGene
Skip Navigation Links.


MA, University of Cambridge

Bar Admissions

England and Wales, Solicitor

Skip Navigation Links.